Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis
Authors:
- Françoise Roudot-ThoravalFRFrançoise Roudot-Thoraval
- Daniel DhumeauxDDDaniel Dhumeaux
- Jean-Michel MétreauJMJean-Michel Métreau
- 1 March 1994
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 106 (3) , 686-690
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant ?-interferon for chronic non-A, non-B hepatitisDigestive Diseases and Sciences, 1991
- Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitisGastroenterology, 1991
- Long‐term follow‐up of chronic hepatitis non‐A, non‐B – with special reference to hepatitis CLiver International, 1991
- Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from FranceHepatology, 1991
- Prolonged treatment (18 months) of chronic hepatitis C with recombinant α-interferon in comparison with a control groupJournal of Hepatology, 1990
- A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitisJournal of Hepatology, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Non-A, Non-B Posttransfusion Hepatitis—A Decade LaterGastroenterology, 1985
- Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.Gut, 1982